Tonix Pharmaceuticals (TNXP) Stock Price, Quote, News & History

Tonix Pharmaceuticals Holding Corp (TNXP) Stock Price, Quote, News & History

TNXPNASDAQ

Trade with Public

$13.75

1.7214.30%

At close: Mar 31, 5:00 PM EST

$13.60

-0.15-1.09%

After Hours: 5:03 PM EST

PRO

Why Is It Moving?™:Tonix Pharmaceuticals Stock Hits New 52-Week Low: What's Driving The Action?

Key Statistics

Open

$12.19

$13.75

Volume / Avg.

504.49K / 423.94K

Day Range

$12.16 - $13.86

52 Wk Range

11.60 - 69.97

Market Cap

$182.31M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

18.46%

Days to Cover

8.16

Recent Tonix Pharmaceuticals Holding Corp News

Tonix Pharmaceuticals Stock Hits New 52-Week Low: What's Driving The Action?

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower Monday morning, hitting a fresh 52-week low as investors weigh a new SEC filing alongside a biotech pipeline update from late last week.

Henry Khederian

Tonix Pharmaceuticals Says Prescriptions For Chronic Pain Drug Top 4,200 Since Launch

Tonix Pharmaceuticals beats expectations, and Tonmya prescriptions grow, with over 4,200 prescriptions since launch.

Vandana Singh

Tonix Pharmaceuticals Stock Dips After Nasdaq Uplisting

Tonix shares fell 2% premarket after the Nasdaq Global Select uplisting, with technical indicators signaling short-term weakness.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-99.84M

Investing Cash Flow (TTM)

-4.53M

Financing Cash Flow (TTM)

214.53M

Free Cash Flow (TTM)

-103.21M

Capital Expenditure (TTM)

-3.37M

Net Change in Cash (TTM)

110.16M

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$45.06M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

7.81

PB Ratio (TTM)

0.66

Earnings Yield % (TTM)

-121.11%

Earnings Yield % (FWD)

-80.67%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$18.29

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$9.65M

Total Cash

$207.64M

Debt to Equity

0.01

Issuance of Debt (TTM)

-$9.65M

Repayment of Debt (TTM)

-$9.65M

Key Statistics

Open

$12.19

$13.75

Volume / Avg.

504.49K / 423.94K

Day Range

$12.16 - $13.86

52 Wk Range

11.60 - 69.97

Market Cap

$182.31M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

18.46%

Days to Cover

8.16

About

Sector

Health Care

Industry

Biotechnology

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of comm...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tonix Pharmaceuticals (TNXP) stock?

You can purchase shares of Tonix Pharmaceuticals (NASDAQ:TNXP) through any online brokerage.

View our list of the best stock brokerages

Who are Tonix Pharmaceuticals (TNXP) competitors?

There are no as such competitors for Tonix Pharmaceuticals.

What is the forecast, or price target, for Tonix Pharmaceuticals (TNXP) stock?

Tonix Pharmaceuticals has a consensus price target of $28.00.

What is the current price for Tonix Pharmaceuticals (TNXP)?

The stock price for Tonix Pharmaceuticals (NASDAQ: TNXP) is $13.6 last updated March 31, 2026 at 5:03 PM EDT.

Does Tonix Pharmaceuticals (TNXP) pay a dividend?

There are no upcoming dividends for Tonix Pharmaceuticals.

When is Tonix Pharmaceuticals (NASDAQ:TNXP) reporting earnings?

Tonix Pharmaceuticals does not have any upcoming earnings scheduled.

Is Tonix Pharmaceuticals (TNXP) going to split?

There is no upcoming split for Tonix Pharmaceuticals.

What sector and industry does Tonix Pharmaceuticals (TNXP) operate in?

Tonix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Key Statistics

Open

$12.19

$13.75

Volume / Avg.

504.49K / 423.94K

Day Range

$12.16 - $13.86

52 Wk Range

11.60 - 69.97

Market Cap

$182.31M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

18.46%

Days to Cover

8.16

Recent Tonix Pharmaceuticals Holding Corp News

Tonix Pharmaceuticals Stock Hits New 52-Week Low: What's Driving The Action?

Henry Khederian

Tonix Pharmaceuticals Says Prescriptions For Chronic Pain Drug Top 4,200 Since Launch

Tonix Pharmaceuticals beats expectations, and Tonmya prescriptions grow, with over 4,200 prescriptions since launch.

Vandana Singh

Tonix Pharmaceuticals Stock Dips After Nasdaq Uplisting

Tonix shares fell 2% premarket after the Nasdaq Global Select uplisting, with technical indicators signaling short-term weakness.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-99.84M

Investing Cash Flow (TTM)

-4.53M

Financing Cash Flow (TTM)

214.53M

Free Cash Flow (TTM)

-103.21M

Capital Expenditure (TTM)

-3.37M

Net Change in Cash (TTM)

110.16M

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$45.06M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

7.81

PB Ratio (TTM)

0.66

Earnings Yield % (TTM)

-121.11%

Earnings Yield % (FWD)

-80.67%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$18.29

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$9.65M

Total Cash

$207.64M

Debt to Equity

0.01

Issuance of Debt (TTM)

-$9.65M

Repayment of Debt (TTM)

-$9.65M

Key Statistics

Open

$12.19

$13.75

Volume / Avg.

504.49K / 423.94K

Day Range

$12.16 - $13.86

52 Wk Range

11.60 - 69.97

Market Cap

$182.31M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

18.46%

Days to Cover

8.16

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tonix Pharmaceuticals (TNXP) stock?

You can purchase shares of Tonix Pharmaceuticals (NASDAQ:TNXP) through any online brokerage.

View our list of the best stock brokerages

Who are Tonix Pharmaceuticals (TNXP) competitors?

There are no as such competitors for Tonix Pharmaceuticals.

What is the forecast, or price target, for Tonix Pharmaceuticals (TNXP) stock?

Tonix Pharmaceuticals has a consensus price target of $28.00.

What is the current price for Tonix Pharmaceuticals (TNXP)?

The stock price for Tonix Pharmaceuticals (NASDAQ: TNXP) is $13.6 last updated March 31, 2026 at 5:03 PM EDT.

Does Tonix Pharmaceuticals (TNXP) pay a dividend?

There are no upcoming dividends for Tonix Pharmaceuticals.

When is Tonix Pharmaceuticals (NASDAQ:TNXP) reporting earnings?

Tonix Pharmaceuticals does not have any upcoming earnings scheduled.

Is Tonix Pharmaceuticals (TNXP) going to split?

There is no upcoming split for Tonix Pharmaceuticals.

What sector and industry does Tonix Pharmaceuticals (TNXP) operate in?

Tonix Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.